Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid, Spain.
Department of Health Science and Technology, Center for Neuroplasticity and Pain (CNAP), SMI, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Pain. 2021 Dec 1;162(12):2832-2840. doi: 10.1097/j.pain.0000000000002306.
This study investigated the association between COVID-related myalgia experienced by patients at hospital admission and the presence of post-COVID symptoms. A case-control study including patients hospitalised due to COVID-19 between February 20 and May 31, 2020, was conducted. Patients reporting myalgia and patients without myalgia at hospital admission were scheduled for a telephone interview 7 months after hospital discharge. Hospitalisation and clinical data were collected from medical records. A list of post-COVID symptoms with attention to musculoskeletal pain was evaluated. Anxiety and depressive symptoms, and sleep quality were likewise assessed. From a total of 1200 hospitalised patients with COVID-19, 369 with and 369 without myalgia at hospital admission were assessed 7.2 months (SD 0.6) after hospital discharge. A greater proportion (P = 0.03) of patients with myalgia at hospital admission (20%) showed ≥3 post-COVID symptoms when compared with individuals without myalgia (13%). A higher proportion of patients presenting myalgia (odds Rratio 1.41, 95% confidence interval 1.04-1.90) exhibited musculoskeletal post-COVID pain when compared to those without myalgia. The prevalence of musculoskeletal post-COVID pain in the total sample was 38%. Fifty percent of individuals with preexisting musculoskeletal pain experienced a worsening of their symptoms after COVID-19. No differences in fatigue, dyspnoea, anxiety/depressive levels, or sleep quality were observed between myalgia and nonmyalgia groups. The presence of myalgia at hospital admission was associated with preexisting history of musculoskeletal pain (OR 1.62, 95% confidence interval 1.10-2.40). In conclusion, myalgia at the acute phase was associated with musculoskeletal pain as long-term post-COVID sequelae. In addition, half of the patients with preexisting pain conditions experienced a persistent exacerbation of their previous syndromes.
这项研究调查了患者入院时 COVID 相关肌痛与新冠后症状存在之间的关联。进行了一项包括 2020 年 2 月 20 日至 5 月 31 日因 COVID-19 住院的患者的病例对照研究。在出院 7 个月后,报告肌痛的患者和入院时无肌痛的患者安排了电话采访。从病历中收集了住院和临床数据。评估了一系列与肌肉骨骼疼痛有关的新冠后症状。同样评估了焦虑和抑郁症状以及睡眠质量。在总共 1200 名因 COVID-19 住院的患者中,有 369 名入院时出现肌痛,369 名入院时无肌痛,在出院后 7.2 个月(SD 0.6)进行了评估。与无肌痛的患者相比,入院时出现肌痛的患者(20%)表现出≥3 种新冠后症状的比例更高(P=0.03)。与无肌痛的患者相比,出现肌痛的患者(比值比 1.41,95%置信区间 1.04-1.90)出现肌肉骨骼新冠后疼痛的比例更高。在总样本中,肌肉骨骼新冠后疼痛的患病率为 38%。50%的有预先存在的肌肉骨骼疼痛的个体在 COVID-19 后经历了症状的恶化。在肌痛和非肌痛组之间,没有观察到疲劳、呼吸困难、焦虑/抑郁水平或睡眠质量的差异。入院时出现肌痛与预先存在的肌肉骨骼疼痛史相关(OR 1.62,95%置信区间 1.10-2.40)。总之,急性肌痛与肌肉骨骼疼痛作为新冠后长期后遗症相关。此外,一半的有预先存在疼痛疾病的患者经历了先前综合征的持续恶化。